Sep 24, 2026
Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs
Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spotlighting cancer treatment.
The post Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Hyperscale Data, Inc. (GPUS) Stock: Soars 34% as Michigan AI Data Center Nears D...
- 1 hour ago
Edible Garden AG (EDBL) Stock Falls Despite New Farm Partnership Targeting 19% G...
- 4 hours ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...
- 11 hours ago
Moderna (MRNA) Stock Drops 17% Despite Melanoma Trial Success
- 11 hours ago
Volvo Shares Hit Record Low After Q3 Loss: What’s Next?